Skip to main content
OPTUS Pharmaceutical Co., Ltd. logo

OPTUS Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 131030 ISIN · KR7131030009 KO Manufacturing
Filings indexed 159 across all filing types
Latest filing 2022-03-23 Transaction in Own Shar…
Country KR South Korea
Listing KO 131030

About OPTUS Pharmaceutical Co., Ltd.

http://optuspharm.com/us/main/index.php

OPTUS Pharmaceutical Co., Ltd. is a specialized pharmaceutical company focused on the research, development, manufacturing, and commercialization of ophthalmic products. The company's primary expertise lies in producing sterile, preservative-free, single-dose (unit-dose) formulations. Its therapeutic portfolio addresses conditions such as dry eye syndrome, keratoconjunctival epithelial disease, bacterial conjunctivitis, and glaucoma. In addition to prescription and over-the-counter pharmaceuticals, the company is expanding into a total eye care model through its OUE& brand, which encompasses nutritional supplements (OUEFIT) and cosmeceuticals (OUELAB). The company operates EU-GMP certified manufacturing facilities and distributes its products globally.

Recent filings

Filing Released Lang Actions
자기주식취득결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식취득결과보고서' (Report on the Results of Treasury Stock Acquisition) filed with the Financial Supervisory Service (FSS) in South Korea. It details the specific dates, quantities, and prices of shares repurchased by the company (DHP Korea) over a specified period. This falls directly under the category of a company reporting its own share buyback activities.
2022-03-23 Korean
주식소각결정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement regarding a '주식소각 결정' (Decision to cancel/retire shares) by DHP Korea. It details the number of shares to be cancelled, the method (using treasury shares), and the purpose (shareholder value enhancement). This falls under capital structure changes and specifically relates to the cancellation of shares, which is categorized under 'Share Issue/Capital Change' (SHA) in the provided taxonomy.
2022-03-23 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for DHP Korea for the fiscal year ending December 31, 2021. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. While it contains financial data, it is the formal audit report required by regulatory standards, not a standalone earnings release or a simple supplement. Therefore, it is classified as an Audit Report. FY 2021
2022-03-18 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for DHP Korea. It contains the meeting agenda, details on voting procedures (electronic voting), and management's report on business activities and financial statements (balance sheet, income statement) to be approved by shareholders. This type of document is standard for proxy solicitation and information statements provided to shareholders ahead of an AGM.
2022-03-08 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion, key financial data, and auditor information for the fiscal year. While it contains financial data, it is a specific regulatory disclosure regarding the completion and submission of the audit report, which falls under the 'Audit Report / Information' category. FY 2021
2022-03-07 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and contains detailed information regarding the upcoming Annual General Meeting (AGM) of DHP Korea, including the meeting date, agenda items (approval of financial statements, election of directors, etc.), and instructions for shareholders to exercise their voting rights via proxy or electronic voting. This document is a standard proxy solicitation statement used to request shareholder votes for an AGM.
2022-03-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.